The product is based on purified Firmicutes bacterial spores delivered in an oral capsule that is designed to encourage the regrowth of healthy bacteria after antibiotic treatment for C.
“C. diff is a really challenging pathogen,” said lead author Joseph Zackular, assistant professor of pathology and laboratory medicine at Penn. “This vaccine is kind of a really nice proof of ...
The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...
New mRNA Vaccine Created to Prevent and Treat C. Difficile Oct. 17, 2024 — A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat ...
But in the future, the treatment could become a cleaner remedy with much broader potential — far removed from the ... One study focused on obesity treatment, and the other on infections with the ...
Desbordante is a high-performance data profiler that is capable of discovering many different patterns in data using various algorithms. It also allows to run data cleaning scenarios using these ...